BGLCBioNexus Gene Lab Corp

Nasdaq bionexusgenelab.com


$ 0.60 $ -0.01 (-2.47 %)    

Monday, 06-May-2024 15:47:44 EDT
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 0.580301
$ 0.60
$ 0.00 x 0
$ 0.00 x 0
$ 0.60 - $ 0.60
$ 0.31 - $ 17.88
58,291
na
10.25M
$ 0.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-16-2024 12-31-2023 10-K
2 11-20-2023 09-30-2023 10-Q
3 08-16-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 04-06-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-18-2021 03-31-2021 10-Q
13 03-30-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 11-03-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 03-31-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bionexus-gene-lab-got-notice-from-nasdaq-that-the-co-is-eligible-for-additional-180-calendar-day-extension-or-until-nov-4-to-regain-compliance

- SEC Filing

 update-bionexus-gene-lab-corp-agrees-to-invest-250k-in-ascension-innovation-aisb-to-advance-digital-health-innovation-through-ai-adoption-in-healthcare

BioNexus Gene Lab Corporation (NASDAQ:BGLC), a global leader in genomic diagnostics and healthcare technology, announces a stra...

 why-sony-shares-are-trading-lower-by-around-6-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financi...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION